Clinical Trial

Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients.

Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated February 7, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
The study purpose is to evaluate the safety of T4090.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-05-24; most recent amendment 2024-12-27.
Status change: Active, Not Recruiting → Completed 2024-12-27
Status change: Recruiting → Active, Not Recruiting 2024-02-06
Status change: Not Yet Recruiting → Recruiting 2022-07-18
Trial Details
NCT Number NCT05389267
Lead Sponsor Laboratoires Thea
Conditions Glaucoma, Ocular Hypertension
Enrollment 120 participants
Start Date 2022-07-05
Primary Completion 2024-12-31 (estimated)
Study Completion 2024-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-02-07